Our Team

Gavin Sathianathan is a recognised advocate for the European cannabis industry. Gavin is the CEO of Alta Flora, a digital health and telemedicine platform focused on novel therapeutics including medical cannabis. Gavin is also co-founder and non-executive director of Oxford Cannabinoid Technologies (OCT), a bio-pharmaceutical business established in conjunction with the University of Oxford.

Gavin has been an advisor to the All Party Parliamentary Group on medical cannabis, regularly works with investors on the evolution of the cannabis market and has advised multiple FTSE 100 CPG companies. He was profiled in the Times of London as “Britain’s Cannabis Capitalist” and named as “marijuana magnate” by The Spectator. Gavin started his career at Bain & Company, spending four years in London before moving to Delhi as part of the founding team of Bain's Indian operation. Gavin then pursued a career in the digital media industry, initially in content creation at Endemol before joining Facebook in Europe as one of the early team to grow the business ahead of the IPO. He was also Managing Director at Tesco, focused on technology, data, and digital media.

Gavin has a degree in Chemical Engineering from Imperial College, London, and an MBA from Harvard Business School.

Jeremy graduated as an Engineer In 2008 and started his career as a corporate stockbroker specialising in raising finance for resources companies with gold companies a particular focus. Working at Pareto Securities (formerly Ocean Equities), Jeremy was promoted to Head of Trading in 2010 and became a Partner in 2012 working on large equity and bond transactions primarily in the resources and shipping sectors. In 2015, Jeremy founded Smaller Company Capital which listed the first publicly traded Blockchain business. Smaller Company Capital went on to finance and list numerous technology and resources companies. Alongside co-founding States Bridge Capital in 2020, Jeremy holds a number of NED and Chairman positions across a range of sectors